T-CELL REPERTOIRES IN HEALTHY AND DISEASED HUMAN TISSUES ANALYZED BY T-CELL RECEPTOR BETA-CHAIN CDR3 SIZE DETERMINATION - EVIDENCE FOR OLIGOCLONAL EXPANSIONS IN TUMORS AND INFLAMMATORY DISEASES

被引:104
作者
EVEN, J
LIM, A
PUISIEUX, I
FERRADINI, L
DIETRICH, PY
TOUBERT, A
HERCEND, T
TRIEBEL, F
PANNETIER, C
KOURILSKY, P
机构
[1] HOP COCHIN,ICGM,INSERM,U152,F-75014 PARIS,FRANCE
[2] INST GUSTAVE ROUSSY,INSERM,U333,F-94800 VILLEJUIF,FRANCE
[3] INST BIOMED CORDELIERS,INSERM,U936,F-75006 PARIS,FRANCE
来源
RESEARCH IN IMMUNOLOGY | 1995年 / 146卷 / 02期
关键词
T LYMPHOCYTE; T-CELL RECEPTOR; OLIGOCLONAL EXPANSION; V-BETA REPERTOIRE; INFLAMMATORY DISEASES; TUMORS;
D O I
10.1016/0923-2494(96)80240-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many examples of oligoclonal T-cell expansion in infiltrated diseased tissues have been reported. However, it remains to be established whether such observations can be generalized and to what extent oligoclonal patterns obtained after in vitro culture of T-cell infiltrates reflect in vivo situations. Using new high resolution analysis which requires no in vitro cellular expansion, we detected such oligoclonal T-cell expansions in 7/7 melanoma tumour biopsies, 3/3 biopsies of inflammatory skin during acute graft versus host disease (aGVHD) after allogeneic bone marrow transplantation (alloBMT) and 7/7 synovial membranes from patients with rheumatoid arthritis. Thus, oligoclonal T-cel expansions are readily observed when a sufficiently sensitive detection method is used, suggesting that similar expansions are the rule among T-cell infiltrates in different diseases. This observation and the monitoring of the in vivo evolution of such expansion during the course of the disease and during in vitro culture should have important clinical implications.
引用
收藏
页码:65 / 80
页数:16
相关论文
共 57 条
  • [21] ANALYSIS OF T-CELL RECEPTOR VARIABILITY IN TUMOR-INFILTRATING LYMPHOCYTES FROM A HUMAN REGRESSIVE MELANOMA - EVIDENCE FOR INSITU T-CELL CLONAL EXPANSION
    FERRADINI, L
    MACKENSEN, A
    GENEVEE, C
    BOSQ, J
    DUVILLARD, P
    AVRIL, MF
    HERCEND, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) : 1183 - 1190
  • [22] GAUDIN C, 1995, CANCER RES, V55, P685
  • [23] AN EXPERIMENTALLY VALIDATED PANEL OF SUBFAMILY-SPECIFIC OLIGONUCLEOTIDE PRIMERS (V-ALPHA-1-W29/V-BETA-1-W24) FOR THE STUDY OF HUMAN T-CELL RECEPTOR VARIABLE V-GENE SEGMENT USAGE BY POLYMERASE CHAIN-REACTION
    GENEVEE, C
    DIU, A
    NIERAT, J
    CAIGNARD, A
    DIETRICH, PY
    FERRADINI, L
    ROMANROMAN, S
    TRIEBEL, F
    HERCEND, T
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (05) : 1261 - 1269
  • [24] DOMINANT CLONOTYPES IN THE REPERTOIRE OF PERIPHERAL CD4(+) T-CELLS IN RHEUMATOID-ARTHRITIS
    GORONZY, JJ
    BARTZBAZZANELLA, P
    HU, WN
    JENDRO, MC
    WALSERKUNTZ, DR
    WEYAND, CM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) : 2068 - 2076
  • [25] GORSKI J, 1994, J IMMUNOL, V152, P5109
  • [26] ANALYSIS OF J BETA GENE SEGMENT USAGE BY CD4+ AND CD8+ HUMAN PERIPHERAL BLOOD-T LYMPHOCYTES
    GRUNEWALD, J
    JEDDITEHRANI, M
    PISA, E
    JANSON, CH
    ANDERSSON, R
    WIGZELL, H
    [J]. INTERNATIONAL IMMUNOLOGY, 1992, 4 (06) : 643 - 650
  • [27] HALL BL, 1992, BIOTECHNIQUES, V13, P248
  • [28] T-CELL RECEPTOR V-BETA GENE USAGE IN ALLOGRAFT-DERIVED CELL-LINES ANALYZED BY A POLYMERASE CHAIN-REACTION TECHNIQUE
    HALL, BL
    FINN, OJ
    [J]. TRANSPLANTATION, 1992, 53 (05) : 1088 - 1099
  • [29] HAWES GE, 1993, J IMMUNOL, V150, P2033
  • [30] HINGORANI R, 1993, J IMMUNOL, V151, P5762